Press Releases

 
Press Releases
  Date Title View
Oct 15, 2015
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its third quarter earnings results after market close on Tuesday, October 27, 2015. Management will hold a conference call to review the Company's financial performance starting at 4:30 p.m. ET on ...
PDF
Aug 6, 2015
Second Quarter Revenue of $7.6 Million, Up 17% Versus Prior Year XT-8 Installed Base Expanded by 29 to 591 European ePlex™ Launch Expected by the End of Fourth Quarter 2015 Full Year Revenue Guidance Maintained at $38-40 Million; Gross Margin Increased to 57-5...
PDF
Jul 30, 2015
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at the 35th Annual Canaccord Genuity Growth Conference to be ...
PDF
Jul 21, 2015
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its second quarter earnings results after market close on Thursday, August 6, 2015. Management will hold a conference call to review the Company's financial performance starting at 4:30 p.m. ET on ...
PDF
May 27, 2015
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at the William Blair 35th Annual Growth Stock Conference to be ...
PDF
May 5, 2015
First Quarter Revenue of $10.1 Million, Up 28% Versus Prior Year XT-8 Installed Base Expanded by 22 to 562 European ePlex™ Launch on Track for Fourth Quarter 2015 Full Year Revenue Guidance Maintained at $38-40 Million CARLSBAD, Calif.--(...
PDF
Apr 29, 2015
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2015 Health Care Conference ...
PDF
Apr 16, 2015
- First Quarter Revenue Expected to be $10.1 million, Up 28% Versus Prior Year- XT-8 Installed Base Expanded by 22 to 562- European ePlex Launch Now Projected for Fourth Quarter 2015- Full Year Revenue Guidance Maintained at $38-40 Million CARLSBAD, Calif.--(BUSINESS WIRE)-- ...
PDF
Feb 24, 2015
Fourth Quarter Revenue $9.8 million, Up 52% Versus Prior Year Gross Margin Increases to 61% in the Fourth Quarter ePlex™ European Launch on Track for Mid-Year CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider...
PDF
Feb 23, 2015
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the appointment of Lisa Giles, President and CEO of Giles & Associates Consultancy, and Michael Kagnoff, a partner at DLA Piper (US...
PDF
FirstPrevious
3
...
NextLast